|
Canada Looks to Boost Rare Disease Research Via Orphan Drug Pathway
Health Canada is developing a new approval pathway for orphan drugs as part of an effort to spur development of drugs for conditions that affect less than five in 10,000 patients.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives